Skip to main content
Journal ArticleOPEN ACCESS

Safety and efficacy of Creon® Micro in children with exocrine pancreatic insufficiency due to cystic fibrosis

Journal of Cystic Fibrosis (2015) 14(2) 275-281
DOI: 10.1016/j.jcf.2014.07.006
14Citations
Citations of this article
67Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Pancreatic enzyme replacement therapy is the foundation of nutritional management for exocrine pancreatic insufficiency (EPI). Methods: A 3-month, open-label, multicentre study in Russia assessing safety, efficacy, and ease-of-use of Creon® Micro (5000 lipase units/spoon) in children aged 1. month to

Author supplied keywords

Cite

CITATION STYLE

APA

Kashirskaya, N. Y., Kapranov, N. I., Sander-Struckmeier, S., & Kovalev, V. (2015). Safety and efficacy of Creon® Micro in children with exocrine pancreatic insufficiency due to cystic fibrosis. Journal of Cystic Fibrosis, 14(2), 275–281. https://doi.org/10.1016/j.jcf.2014.07.006

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free